Clinical Trial Detail

NCT ID NCT04145622
Title Study of DS-7300a in Participants With Advanced Solid Malignant Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Daiichi Sankyo Co., Ltd.
Indications

urinary bladder cancer

breast cancer

lung squamous cell carcinoma

head and neck squamous cell carcinoma

lung adenocarcinoma

endometrial cancer

esophagus squamous cell carcinoma

melanoma

sarcoma

prostate cancer

Therapies

DS-7300a

Age Groups: adult senior

No variant requirements are available.